EQUITY RESEARCH MEMO

Delee

Generated 5/23/2026

Executive Summary

Conviction (model self-assessment)60/100

Delee is a Mexico City-based company advancing digital health and medical devices to improve patient care and healthcare delivery. Founded in 2018, the company has reached the commercial stage with a team of 10-50 employees. Operating in a large and underserved healthcare market, Delee offers integrated solutions that likely include telemedicine platforms, remote patient monitoring, or diagnostic devices. Its commercial traction positions it to capture share in Mexico's growing digital health sector, which benefits from increasing smartphone penetration and government incentives for healthcare modernization. While financial details remain undisclosed, the company's early commercial success and focus on scalable digital solutions suggest a promising growth trajectory.

Upcoming Catalysts (preview)

  • Q3 2026Launch of next-generation digital health platform70% success
  • Q4 2026Strategic partnership with a major hospital network in Mexico60% success
  • Q2 2026COFEPRIS or FDA clearance for a new medical device75% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)